Home > Benfotiamine and cognitive decline in Alzheimer’s disease: Results of a randomized placebo-controlled phase IIa clinical trial.
Benfotiamine and cognitive decline in Alzheimer’s disease: Results of a randomized placebo-controlled phase IIa clinical trial.
Manuscript Number:
20-0896R1
Author(s):
Lucien Bettendorff, Huanlian Chen, Zhengming Chen, Rosanna Cirio, Sarah Flowers, Pasquale Fonzetti, Jessica Franchino-Elder, Linda Gerber, Gary E. Gibson, Thomas Grandville, Christian Habeck, Joseph A. Hirsch, Barry Jordan, Jose A. Luchsinger, Nicole Schupf, Yaakov Stern, Hui Xu
